Cargando…

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

BACKGROUND: Routine fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies is still controversial, because of antibiotic resistance concerns. The recovery of the fecal microbiota to the initial composition in patients receiving multiple courses of quinolone prophylaxis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Yong, Shimoda, Shinji, Miyake, Noriko, Aoki, Takatoshi, Ito, Yoshikiyo, Kamimura, Tomohiko, Shimono, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500534/ https://www.ncbi.nlm.nih.gov/pubmed/28721078 http://dx.doi.org/10.2147/IDR.S133333

Ejemplares similares

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
por: Chong, Yong, et al.
Publicado: (2014)

Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
por: Chong, Yong, et al.
Publicado: (2013)

Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study
por: Sumida, Kosuke, et al.
Publicado: (2015)

Helicobacter cinaedi Bacteremia Mimicking a Flare of Systemic Lupus Erythematosus
por: Nishida, Ruriko, et al.
Publicado: (2017)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2019)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

Fluoroquinolone-resistant Escherichia coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy – possible shift in biopsy prophylaxis
por: Adamczyk, Przemysław, et al.
Publicado: (2017)

Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020
por: Nishida, Ruriko, et al.
Publicado: (2023)

Neutropenia and Infection Prophylaxis in Childhood Cancer
por: Villeneuve, Stephanie, et al.
Publicado: (2022)

The Co-Selection of Fluoroquinolone Resistance Genes in the Gut Flora of Vietnamese Children
por: Vien, Le Thi Minh, et al.
Publicado: (2012)

The Fecal Viral Flora of Wild Rodents
por: Phan, Tung G., et al.
Publicado: (2011)

Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora
por: Son, Kyung Chul, et al.
Publicado: (2018)

Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora
por: Lim, Do Gyeong, et al.
Publicado: (2021)

Viral Findings in Adult Hematological Patients with Neutropenia
por: Öhrmalm, Lars, et al.
Publicado: (2012)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
por: Heussel, Claus Peter
Publicado: (2014)

THE EFFECT OF ANTIBACTERIAL DRUGS ON THE FECAL FLORA OF MICE
por: Dubos, Rene, et al.
Publicado: (1963)

Metagenomic Analysis of the Ferret Fecal Viral Flora
por: Smits, Saskia L., et al.
Publicado: (2013)

Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistance
por: Nair, Ashwin, et al.
Publicado: (2023)

Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
por: Cerchione, Claudio, et al.
Publicado: (2021)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Small intestinal flora graft alters fecal flora, stool, cytokines and mood status in healthy mice
por: Xie, Yinyin, et al.
Publicado: (2021)

THE EFFECT OF DIET ON THE FECAL BACTERIAL FLORA OF MICE AND ON THEIR RESISTANCE TO INFECTION
por: Dubos, René J., et al.
Publicado: (1962)

Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
por: Clerici, Daniela, et al.
Publicado: (2022)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
por: Innocenti, Rolando, et al.
Publicado: (2018)

Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia
por: Teofili, Luciana, et al.
Publicado: (2016)

Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia
por: Voulgaridou, Aikaterini, et al.
Publicado: (2020)

A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
por: He, Na, et al.
Publicado: (2020)

Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study
por: Riedel, Amy, et al.
Publicado: (2007)

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015)

Efficacy of using trimethoprim‐sulfamethoxazole prophylaxis in an adult patient with autoimmune neutropenia
por: Azuma, Naoto, et al.
Publicado: (2019)

THE FECAL FLORA OF VARIOUS STRAINS OF MICE. ITS BEARING ON THEIR SUSCEPTIBILITY TO ENDOTOXIN
por: Schaedler, Russell W., et al.
Publicado: (1962)

Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2020)

430 Patients with Prolonged (>10 days) Neutropenia Displayed Similar IFI Rates Regardless of Hematologic Diagnosis and Chemotherapy Status: A Challenge to Antifungal Prophylaxis Decisions
por: Saxinger, Lynora, et al.
Publicado: (2014)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum]
Publicado: (2019)

Clinical significance of SARS‐CoV‐2‐specific IgG detection with a rapid antibody kit for COVID‐19 patients
por: Chong, Yong, et al.
Publicado: (2020)

1087. Fluoroquinolone Prophylaxis vs. No Bacterial Prophylaxis in Hospitalized Neutropenic Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia
por: Buchanan, Carley, et al.
Publicado: (2019)

Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia
por: Ribeiro, A.F. Tibúrcio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jj9128hu7denfe2sbqv4nhfu0m